back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 18:05 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
McAdory, John Bearden
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
1 | ||
| Filed 2026-06-04 17:36 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
McAdory, John Bearden
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,700
+145,000 vol $1.06 each |
645,000 | |
| Filed 2026-06-04 17:34 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
McAdory, John Bearden
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2026-06-04 17:16 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Glover, Stephen C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$101,760
+96,000 vol $1.06 each |
96,000 | |
| Filed 2026-06-04 17:13 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Glover, Stephen C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-04 16:52 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,600
+260,000 vol $1.06 each |
1,007,994 | |
| Filed 2026-06-04 16:50 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,600
+260,000 vol $1.06 each |
1,560,000 | |
| Filed 2026-06-04 16:48 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,600
+260,000 vol $1.06 each |
1,724,200 | |
| Filed 2026-06-04 16:46 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,600
+260,000 vol $1.06 each |
1,771,878 | |
| Filed 2026-06-04 16:43 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$800,300
+755,000 vol $1.06 each |
6,305,000 | |
| Filed 2026-06-04 16:40 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
225,000 | |
| Filed 2026-06-04 16:37 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
285,000 | |
| Filed 2026-06-04 16:33 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
270,000 | |
| Filed 2026-06-04 16:31 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
270,000 | |
| Filed 2026-06-04 16:27 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
275,263 | |
| Filed 2026-06-04 16:25 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
285,000 | |
| Filed 2026-06-04 16:21 Tx date 2026-06-01 |
$ONCY
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,800
+30,000 vol $1.06 each |
300,000 | |
| Filed 2026-03-13 09:06 Tx date 2026-03-11 |
$ONCY
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+10,000 vol $1.03 each |
41,849 | |
| Filed 2026-03-13 09:04 Tx date 2026-03-12 |
$ONCY
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,848
+5,050 vol $0.96 each |
114,050 | |
| Filed 2026-03-09 18:37 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
240,000 |